ERBB2 and breast carcinoma: Breast cancer in patients can be molecularly characterized by parameters, such as ER or HER2 status, and generally fall into four subtypes determined by gene expression patterns: Luminal A, Luminal B, HER2+, and Basal (triple-negative breast cancer).